KASHIV BIOSCIENCES

Kashiv BioSciences is a fully-integrated biopharmaceutical company with global R&D, clinical, regulatory, and manufacturing capabilities. The company was originally formed as a specialty pharmaceutical business and has since transformed itself to develop and deploy its end-to-end biosimilars platform and aggressively expand its pipeline. In the first half of 2022, Kashiv validated its biosimilars platform after receiving FDA approvals for RELEUKO® (biosimilar to NEUPOGEN®) and FYLNETRA® (biosimilar to NEULASTA®)... Our vision is to become a leading global biopharmaceutical company that develops and manufactures effective and differentiated therapeutics to meet unmet medical needs.

Also known as: Kashiv BioSciences, LLC

Primary location: Piscataway United States